{"title":"Real-world efficacy of plano lenses with highly aspherical lenslets in children with pre-myopia: A prospective cohort study.","authors":"Aimin Sun, Xueli Li, Pingping Zhu, Fenghua Xie, Yuan Wu","doi":"10.1111/opo.13535","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the efficacy of plano lenses (PLs) with highly aspherical lenslets (HALs) in controlling axial length (AL) progression in pre-myopic children.</p><p><strong>Methods: </strong>This prospective cohort study enrolled 103 children aged 6-12 years with a spherical equivalent refraction (SE) between -0.50 and +0.75 D. Participants were assigned to either a treatment group wearing PLs with HALs or a control group receiving no intervention. AL and SE were measured at baseline (V0), 3 months (V1), 6 months (V2) and 12 months (V3). Monthly changes in AL were calculated for V0-V1, V1-V2 and V2-V3 intervals. Repeated measures-ANOVA was performed to analyse AL changes across time intervals within and between groups.</p><p><strong>Results: </strong>A total of 95 children (8.0 ± 1.4 years) completed the study, with 46 in the treatment group and 49 in the control group. After 12 months, the treatment group showed significantly less myopic progression (0.13 ± 0.12 D) compared with the control group (0.43 ± 0.16 D; p < 0.01). AL elongation was also lower in the treatment group than in the control group (0.16 ± 0.16 mm vs. 0.30 ± 0.16 mm; p < 0.001). Monthly AL changes remained consistently lower in the treatment group across all intervals. In the treatment group, the monthly AL change was notably lower in V0-V1 than in either V1-V2 or V2-V3, whereas there were no comparable significant differences in the control group.</p><p><strong>Conclusion: </strong>PL/HALs can effectively control AL growth in pre-myopic children, with the most significant impact occurring within the first 3 months of wear.</p>","PeriodicalId":520731,"journal":{"name":"Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/opo.13535","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To assess the efficacy of plano lenses (PLs) with highly aspherical lenslets (HALs) in controlling axial length (AL) progression in pre-myopic children.
Methods: This prospective cohort study enrolled 103 children aged 6-12 years with a spherical equivalent refraction (SE) between -0.50 and +0.75 D. Participants were assigned to either a treatment group wearing PLs with HALs or a control group receiving no intervention. AL and SE were measured at baseline (V0), 3 months (V1), 6 months (V2) and 12 months (V3). Monthly changes in AL were calculated for V0-V1, V1-V2 and V2-V3 intervals. Repeated measures-ANOVA was performed to analyse AL changes across time intervals within and between groups.
Results: A total of 95 children (8.0 ± 1.4 years) completed the study, with 46 in the treatment group and 49 in the control group. After 12 months, the treatment group showed significantly less myopic progression (0.13 ± 0.12 D) compared with the control group (0.43 ± 0.16 D; p < 0.01). AL elongation was also lower in the treatment group than in the control group (0.16 ± 0.16 mm vs. 0.30 ± 0.16 mm; p < 0.001). Monthly AL changes remained consistently lower in the treatment group across all intervals. In the treatment group, the monthly AL change was notably lower in V0-V1 than in either V1-V2 or V2-V3, whereas there were no comparable significant differences in the control group.
Conclusion: PL/HALs can effectively control AL growth in pre-myopic children, with the most significant impact occurring within the first 3 months of wear.